Welcome!

Recurring Revenue Authors: Yeshim Deniz, Carmen Gonzalez, Liz McMillan, Pat Romanski, Elizabeth White

News Feed Item

Pharmaceutical Marketing in an Era of Continuous Change

Rosangela Checchia, Chief Executive Officer, Checon Pesquisa,

New York, NY, May 16, 2012 - (ACN Newswire) - "We live in an environment of continuous change and unlimited access to knowledge. Given the regulatory issues, constraints and ethical aspects involved in the pharmaceutical industry, knowing how to act in this reality is critical," says Rosangela Checchia, Chief Executive Officer, Checon Pesquisa. There are new metrics in the market that can help pharmaceutical marketing executives overcome some of these challenges, increase profitability and become more accurate in decision-making, she adds.

From a research and consulting agency at the marcus evans PharmaBrand Summit 2012, in Munich, Germany, 11 - 13 June, Checchia shares her insights into pharmaceutical product marketing and how eye-tracking technologies can be effective in this arena.

- What would help pharmaceutical marketers make better decisions?

We live in very dynamic times, with the Internet and social media networks creating an environment of continuous change and unlimited access to information. Knowing how toact in this new reality is a challenge to all business areas, especially the pharmaceutical industry. In the BRIC countries, especially Brazil, organisations must understand the new Brazilian consumer, who is more educated, optimistic, affluent, informed and connected to the world than before, and therefore more demanding. New market research has made important contributions for more accurate decision-making.

- How can eye-tracking technology help pharmaceutical marketing be more effective?

This is an innovative measurement process with many possible applications. By examining fixations, saccades, pupil dilation, blinks and a variety of other behaviours, researchers can determine the effectiveness of a given medium or product.

Itis a considerable advantage to know what information has actually been perceived in graphic pieces, websites, portals, blogs, newspaper advertisements or publications, films, TV commercials, package designs or shelf displays. It is now possible to measure the retention time of someone's gaze and the sequence of images and content that is perceived and assimilated. This provides a huge step forward for the marketer to transcend from the realm of assumption (and guesswork) to that of highly precise and reliable measurement. Even information comprehension can be measured, signalling and indicating where there is a need for clearer and more objective language. All of these innovative results can add significant value to product and brand management, by providing insights into emotional responses and reactions.

- What initiatives work at establishing brand loyalty? What are consumers looking for?

Nowadays consumers take the quality of pharmaceutical products for granted. Prices must be within reason for companies to achieve their sales targets, but given the increasing commoditisation of products, brand importance has increased.

There is no magic formula for achieving brand loyalty or increasing market share, but new market research certainly helps us understand the different realities, cultures and needs (of countries, types of patients and communities) and provides us with a deeper understanding of all those involved in the relationship. Understanding and listeningto clients helps build loyalty, but this takes time, directed communication and research efforts on a broad spectrum.

We are beyond the era of asking, measuring and analysing. The future is about listening, co-creating and measuring emotions.


About the PharmaBrand Summit 2012

This unique forum will take place at the Four Seasons Kempinski Hotel, Munich, Germany, 11 - 13 June 2012. Offering much more than any conference, exhibition or trade show, this exclusive meeting will bring together esteemed industry thought leaders and solution providers to a highly focused and interactive networking event. The Summit includes presentations and discussion panels on the future of healthcare, digital marketing and stakeholder engagement that bring insight from pharma, medtech and biotech marketers, payer and patient perspectives, as well as out-of-industry case studies. For more information please send an email to [email protected] or visit the event website at www.pharmabrandeurope.com/RosangelaChecchiaInterview

marcus evans group - marketing sector portal - http://bit.ly/a0XVaF

The Marketing Network - marcus evans Summits group delivers peer-to-peer information on strategic matters, professional trends and breakthrough innovations.
- LinkedIn: www.linkedin.com/groups?mostPopular=&gid=3379860&trk=myg_ugrp_ovr
- YouTube: www.youtube.com/user/MarcusEvansMarketing
- Twitter: www.twitter.com/meSummitsMkt
- Slideshare: www.slideshare.net/MarcusEvansMarketing Please note that the Summit is a closed business event and the number of participants strictly limited.

About Checon Pesquisa

Established in 1992, certified ISO 20.252 with international accreditation, Checon Pesquisa is a full-service research and consulting agency. We help companies achieve financial gain through a deep understanding of customers, channel partners and employees, blending the best science, innovative technology and business expertise to generate high quality survey data.We have our own focus groups and CATI facilities and eye tracker. For more information: www.checonpesquisa.com.br.

About marcus evans Summits

marcus evans Summits are high level business forums for the world's leading decision-makers to meet, learn and discuss strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to individually tailor their schedules of keynote presentations, think tanks, seminars and one-on-one business meetings. For more information, please visit www.marcusevans.com.

- Twitter: www.twitter.com/meSummitsGlobal
- YouTube: www.youtube.com/user/MarcusEvansGroup
- SlideShare: www.slideshare.net/MarcusEvansSummits

Source: marcus evans Summits

Contact:
Sarin Kouyoumdjian-Gurunlian
Press Manager, marcus evans, Summits Division
Tel: + 357 22 849 313
Email: [email protected]




Copyright 2012 ACN Newswire. All rights reserved.

More Stories By ACN Newswire

Copyright 2008 ACN Newswire. All rights reserved. Republication or redistribution of ACN Newswire content is expressly prohibited without the prior written consent of ACN Newswire. ACN Newswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

IoT & Smart Cities Stories
Nicolas Fierro is CEO of MIMIR Blockchain Solutions. He is a programmer, technologist, and operations dev who has worked with Ethereum and blockchain since 2014. His knowledge in blockchain dates to when he performed dev ops services to the Ethereum Foundation as one the privileged few developers to work with the original core team in Switzerland.
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
Dynatrace is an application performance management software company with products for the information technology departments and digital business owners of medium and large businesses. Building the Future of Monitoring with Artificial Intelligence. Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more busine...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
Whenever a new technology hits the high points of hype, everyone starts talking about it like it will solve all their business problems. Blockchain is one of those technologies. According to Gartner's latest report on the hype cycle of emerging technologies, blockchain has just passed the peak of their hype cycle curve. If you read the news articles about it, one would think it has taken over the technology world. No disruptive technology is without its challenges and potential impediments t...
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
Bill Schmarzo, Tech Chair of "Big Data | Analytics" of upcoming CloudEXPO | DXWorldEXPO New York (November 12-13, 2018, New York City) today announced the outline and schedule of the track. "The track has been designed in experience/degree order," said Schmarzo. "So, that folks who attend the entire track can leave the conference with some of the skills necessary to get their work done when they get back to their offices. It actually ties back to some work that I'm doing at the University of San...
When talking IoT we often focus on the devices, the sensors, the hardware itself. The new smart appliances, the new smart or self-driving cars (which are amalgamations of many ‘things'). When we are looking at the world of IoT, we should take a step back, look at the big picture. What value are these devices providing. IoT is not about the devices, its about the data consumed and generated. The devices are tools, mechanisms, conduits. This paper discusses the considerations when dealing with the...